Search - tctmd.com

Displaying 101 - 120 of 553

Sort: Relevancy | Date

Presentation TCT 2017

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles

October 31, 2017

Presentation TCT 2017

Left Main PCI in the Emergent Setting (STEMI, Catheter-Induced Dissection, Coronary Obstruction During TAVR, and More)

Presenter: David Hildick-Smith, Jeffrey W. Moses, Giovanni GB Pedrazzini

October 31, 2017

Presentation TCT 2017

Cardiac Catheterization, Mechanical Support, and Hypothermia in Patients With Cardiac Arrest: State-of-the-Art

Presenter: Michael Mooney, Holger Thiele, Sandeep Nathan

October 31, 2017

Presentation TCT 2017

Should the Approach to Multivessel Disease Differ in Patients With and Without Cardiogenic Shock?

Presenter: Michael Mooney, Holger Thiele

October 31, 2017

Presentation TCT 2017

Hub and Spoke Transfer Strategies in Cardiogenic Shock and Cardiac Arrest: Any Benefit on Outcome?

Presenter: Michael Mooney, Holger Thiele, Christopher B. Granger

October 31, 2017

Presentation TCT 2017

Improving Outcomes in Cardiogenic Shock: Issues the Guidelines Dont Discuss

Presenter: Michael Mooney, Holger Thiele, Venu Menon

October 31, 2017

Presentation TCT 2017

Case Presentation: A Patient With Multivessel Disease in STEMI

Presenter: Stefan K. James, Ran Kornowski, Marco V. Wainstein

October 31, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Watchful Waiting Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Deepak L. Bhatt

October 31, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Staged Revascularization After Ischemia Testing Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Thomas Engstroem

October 31, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Anthony H. Gershlick

October 31, 2017

Presentation TCT 2017

When, If Ever, Should Stent Implantation Be Deferred in STEMI?

Presenter: Stefan K. James, Ran Kornowski, Jacob Lønborg, MD

October 31, 2017

Presentation TCT 2017

Case Presentation: No Reflow After Primary PCI

Presenter: David P. Faxon, Robert S. Schwartz, Mohamed Abdel-Wahab

October 31, 2017

Presentation TCT 2017

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Presenter: David P. Faxon, Robert S. Schwartz, Stefan K. James

October 31, 2017

Presentation TCT 2017

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

Presenter: David P. Faxon, Robert S. Schwartz, Raffaele Piccolo

October 31, 2017

Presentation TCT 2017

Coronary Flow, Collateral Flow, and Fractional Flow Reserve in Culprit and Nonculprit Lesions in STEMI

Presenter: David P. Faxon, Robert S. Schwartz, Matthias Götberg

October 31, 2017

Presentation TCT 2017

Recognition, Diagnosis, and Management of Spontaneous Coronary Artery Dissection

Presenter: David P. Faxon, Robert S. Schwartz, Jacqueline Saw

October 31, 2017

Presentation TCT 2017

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

US Trial Background and Update: Preserve-AMI

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

Presenter: Thomas F. Luscher, David Erlinge

October 31, 2017

Advertisement

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Left Main PCI in the Emergent Setting (STEMI, Catheter-Induced Dissection, Coronary Obstruction During TAVR, and More)

Cardiac Catheterization, Mechanical Support, and Hypothermia in Patients With Cardiac Arrest: State-of-the-Art

Should the Approach to Multivessel Disease Differ in Patients With and Without Cardiogenic Shock?

Hub and Spoke Transfer Strategies in Cardiogenic Shock and Cardiac Arrest: Any Benefit on Outcome?

Improving Outcomes in Cardiogenic Shock: Issues the Guidelines Dont Discuss

Case Presentation: A Patient With Multivessel Disease in STEMI

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Watchful Waiting Is the Preferred Strategy!

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Staged Revascularization After Ischemia Testing Is the Preferred Strategy!

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

When, If Ever, Should Stent Implantation Be Deferred in STEMI?

Case Presentation: No Reflow After Primary PCI

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

Coronary Flow, Collateral Flow, and Fractional Flow Reserve in Culprit and Nonculprit Lesions in STEMI

Recognition, Diagnosis, and Management of Spontaneous Coronary Artery Dissection

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

US Trial Background and Update: Preserve-AMI

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content